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The purpose of this study was to test an explanatory theory of decision-making in women eligible for a cancer clini-
cal trial. The theory derived fromKing’s framework proposed that the concepts of uncertainty, role functioning, and
social support relate to emotional health (hope and mood state), which in turn relates to the treatment decision. A
correlational study design was used to test the theory in a sample of 40 women. Findings provided empirical evi-
dence of the adequacy of King’s framework and supported, in part, theorized relationships among the critical fac-
tors. However, these factors did not illuminate the treatment decision.
Optimal cancer treatments can only
be devised through patient enrollment
in cancer clinical trials. Yet, less than
3% of all persons with cancer enroll in
clinical trials (Ho, 1994; National Can-
cer Institute, 2000; Tejeda et al., 1996).
There remains a critical need to increase
the number of persons with cancer who
participate in clinical trials. Because
women have been grossly
underrepresented in multiple therapeu-
tic areas of investigations (Thomas,
1997), it is vital to understand their
unique approach to decision-making re-
garding clinical trial enrollment. De-
spite efforts by social scientists and
physicians to study the phenomenon of
cancer clinical trial enrollment, the
problem of low and slow enrollment
persists (Gotay, 1991). The inadequate
specification of the personal and psy-
chological factors of patient refusal, as
well as the complexity of the response
regarding entry into the clinical trial, are
no doubt responsible, to a great extent,
for the lack of progress. Clearly, there is
an expedient need to improve under-
standing of the patient factors surround-
ing the enrollment process (Huizinga,
Sleijfer, van de Wiel, & van der Graaf,
1999; Schain, 1994).
Recently, nurse researchers have be-
gun to investigate the psychosocial as-
pects of the cancer clinical trial enroll-
ment process (Cox & Avis, 1996;
Crago, Schaefer, & Gyaunch, 1997;
Yoder, O’Rourke, Etnyre, Spears, &
Brown, 1997). Previous findings from
Dwyer’s (1993) research on decision-
making maintained that the cancer pa-
tient’s decision relies primarily on hu-
man emotion and less on the cognition
of decision analysis, expected utility
theory, or judgment heuristics. Addi-
tionally, Dwyer (1993) found that the
actual decision is dependent on how the
patient sees the self as able to pursue
and psychologically manage a given
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treatment. Dwyer not only emphasized
the role of human emotions but also the
role of emotional wellness or health in
the decision-making process. These
findings by Dwyer are congruent with
the theoretical perspective offered by
King (1981). Both King and Dwyer em-
phasized the individual’s perception of
the situation and the nature of subjectiv-
ity in the decision-making process. To
date, studies that examine the psycho-
social influences on women’s emo-
tional health in relation to the treatment
decision have been absent from the lit-
erature. This article describes the test-
ing of a theory of decision-making in
women eligible for a cancer clinical trial.
Background
Identifying barriers to optimal clini-
cal trial accrual and subsequently devel-
oping strategies to overcome them are
of critical importance (Gotay, 1991).
Despite the urgent need for effective
strategies, there are only a few system-
atic studies of patients in cancer clinical
trials, and the findings rarely go beyond
demographics and exclusion criteria
(Gotay, 1991; Swanson & Ward, 1995).
Patient demographic characteristics
such as age and sociodemographic sta-
tus are fairly well understood in the en-
rollment process; however, they are not
readily changeable or amenable to in-
terventions to increase accrual (Mor-
row, Hickock, & Burish, 1994). Addi-
tionally, these characteristics are
inadequate by themselves in explaining
the patient’s emotional health. Gotay
(1991) recommended that additional re-
search should focus on the perspectives
of patients who accept and decline trial
participation and on subsequent inter-
ventions designed to affect enrollment.
Yet rarely have the perspectives of pa-
tients been assessed. Given the com-
plexity of the patient’s response regard-
ing entry into or avoidance of a clinical
trial, Schain (1994) maintains that re-
searchers must try and isolate a few of
the major variables to learn more about
this phenomenon. Cox and Avis (1996)
and Yoder et al. (1997) clearly identi-
fied the significance of hope in the en-
rollment process, whereas Crago et al.
(1997) identified the significance of un-
certainty and social support. Therefore,
the present nursing study extends the
previous patient-focused research on
demographics and exclusion criteria. It
builds on the previous studies by Cox
and Avis (1996), Crago et al. (1997),
Dwyer (1993), and Yoder et al. (1997),
but goes beyond those studies by assess-
ing the indicators of emotional health
and the relationship between emotional
health and enrollment. This research
was designed to begin addressing the
critical issues raised by Dwyer (1993),
Gotay (1991), and Schain (1994).
Purpose of the Study
The purpose of this study was to test
an explanatory theory of decision-mak-
ing derived from King’s (1981) frame-
work in women who had been given the
option to enroll in a cancer treatment
trial. The theory proposes that concepts
of uncertainty, role functioning, and so-
cial support relate to emotional health
(hope and mood state), which in turn re-
lates to the treatment decision. The pri-
mary research questions formulated to
test the proposed theory were: (a) What
is the extent of the relationship among
personal, interpersonal, and social sys-
tems’ concepts (uncertainty, role func-
tioning, social support) and emotional
health (hope and mood state)? and (b)
What is the extent of the relationship be-
tween emotional health (hope and mood
state) and the treatment decision?
Conceptual Framework and Theory
King’s (1981) framework provides a
reference for the domain of nursing. It is
based on the overall assumption that the
focus of nursing is human beings inter-
acting with their environment leading to
a state of health for individuals (King,
1981). This framework consists of three
interacting systems: the personal sys-
tem, the interpersonal system, and the
social system. The boundaries of each
system are open, such that each system
influences the others. In each system
there are interrelated concepts such as
perception, role, and organization. King
(1995) asserted, “This framework dif-
fers from other conceptual schema in
that it is concerned not with fragment-
ing human beings and the environment
but with human transactions in different
types of environments” (p. 21). The the-
ory derived from King’s (1981) frame-
work proposes relationships between
the variable of emotional health and
several systems concepts: (a) the
woman’s uncertainty about the illness
situation, (b) her ability to function in
her roles, and (c) her social support net-
work. A relationship between emo-
tional health and the treatment decision
is also proposed. The concepts are
linked to King’s systems as indicated in
Figure 1. These linkages, also sup-
ported with the literature pertaining to
cancer nursing and cancer clinical tri-
als, are further described here.
King’s (1981) personal system con-
tained several key concepts, including
perception. According to Mishel
(1983), uncertainty is a perceptual vari-
able. When a physician presents a clini-
cal trial as a treatment option to an indi-
vidual, it introduces into the illness
situation the fact that the best answer for
treating the illness remains unknown.
Stetz (1993) stated that little is known
about how patients manage uncertainty
with respect to making the decision to
enter a clinical trial. Uncertainty occurs
when the decision maker (the woman
eligible for a cancer clinical trial) is un-
able to assign definite values to objects
and events and/or is unable to accu-
rately predict outcomes (Mishel, 1988).
Moreover, perceptions of uncertainty
can lead to problems in psychosocial
adjustment and a pessimistic view of the
future (Mishel, 1983).
King’s (1981) description of the in-
terpersonal system contained the con-
cept of role. According to King, several
elements give meaning to the concept of
role, including the “relationship with
one or more individuals interacting in
specific situations for a purpose” (p.
93). Whereas the ability or inability to
function in roles is certainly related to
health, it is not the overall definition of
health (Winker, 1995). Role function in
the tested theory is clearly viewed as in-
fluencing health or, more precisely,
emotional health. Accordingly, “role
Cancer Clinical Trials 157
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functioning refers to the degree to
which an individual performs or has the
capacity to perform activities typical for
a specified age and social responsibil-
ity” (Sherbourne, Stewart, & Wells,
1992, p. 205). Unfortunately, the impor-
tant roles held by women have often not
been assessed in the context of role
functioning (Sherbourne et al., 1992).
During the treatment decision-making
process, the person with cancer must
rebalance his or her roles within the
family and society while attempting to
regain and maintain a state of physical
and emotional well-being (Dwyer,
1993). Women may have a more diffi-
cult time rebalancing the roles because
of role multiplicity, which in turn may
create distress.
King (1981) characterized social
systems as the family, religious sys-
tems, work systems, educational sys-
tems, and peer groups. King identified
the organization as a major concept of
the social system, noting an “organiza-
tion as a system exhibits patterns of in-
dividual and group behavior, patterns of
communication, and patterns of interac-
tion” (p. 121). Thus, an organization
can represent a social support system.
Family support can be a significant fac-
tor in the patient’s decision-making pro-
cess as members provide emotional
support throughout the process
(Johansen, Mayer, & Hoover, 1991).
Conversely, the absence of informal and
formal networks can pose major prob-
lems to patients with cancer who are
seeking care (Guidry et al., 1996). Mor-
row et al. (1994) went so far as to say
that “support groups may improve the
likelihood of study entry of patients
with inadequate social networks” (p.
2681). The presence or absence of an
adequate social support system or net-
work may influence how the individual
emotionally pursues the decision to par-
ticipate in a complex clinical trial.
King (1971) stated that health “en-
compasses the whole man [sic]—physi-
cal, emotional, and social . . . within the
cultural pattern in which he [sic] was
born and to which he [sic] attempts to
conform” (p. 67). King (1981) also
stated that the goal of nursing “is to help
individuals maintain their health so they
can function in their roles” (pp. 3-4). In
examining King’s (1971, 1981) various
definitions of health, Winker (1995)
noted, “Limiting the definition of health
to role function does not comprehend
the interaction of people and the uni-
verse and the teleological nature of hu-
manity” (p. 42). Therefore, a new defi-
nition of health is created by Winker
(1995), who stated that “health is the
ability of the individual to create mean-
ingful symbols based on either biologi-
cal or human values within his or her
cultural and individual value systems”
(p. 42). Furthermore, Dwyer (1993) be-
lieved that there is a relationship be-
tween the process of making the treat-
ment decision and emotional well-
being. In the proposed theory, health is
viewed as emotional health that takes
into account King’s (1971) and Winker’s
(1995) definitions of health. A state of
emotional health is desired prior to en-
gaging in an active course of cancer
therapy, although it is not always pres-
ent in optimal form due to factors such
as grief or denial (Dwyer, 1993). Within
the theory, the indicators of emotional
health are hope and mood state.
King (1981) stated, “Decisions are
individual, personal, and subjective” (p.
132). Dwyer (1993) contended that for
the person with cancer, the treatment
decision stems from human emotion,
which the proposed theory conceptual-
izes as emotional health. The action of
decision-making manifests itself in the
treatment decision. Therefore, the treat-
ment decision is consenting to enter or
not to enter the clinical trial.
158 Nursing Science Quarterly, 15:2, April 2002
Figure 1. Conceptual-Theoretical-Empirical Structure
 at UNIV OF TENNESSEE on August 3, 2010nsq.sagepub.comDownloaded from 
Methodology
Design
A descriptive, correlational study
design was used. The primary measure-
ments of all variables were made at en-
try into this study using self-report, pa-
per-and-pencil scales that were
conceptually linked with empirical in-
dicators of the concepts in the theory
(see Figure 1). This approach yielded
reports about emotional health in close
relation to the precise day of finalizing
the treatment decision. The design
avoided placing high demands on the
participant, which could lead to refusal
to participate in the proposed nursing
study (Hinds, Quargnenti, & Madison,
1995).
Sample and Setting
A sample of women newly diag-
nosed with cancer was drawn from four
cancer care facilities. A woman was eli-
gible for participation if she: (a) was at
least 18 years old, (b) could communi-
cate in English verbally and in writing,
(c) had a cancer diagnosis ≤ 6 months,
(d) had a Karnofsky Performance Status
(KPS) score of ≥ 60, (e) had no history
of psychiatric illness, (f) had been given
the option to enroll in a treatment trial
by her physician, and (g) reported the
personal treatment decision had been
made 28 days prior. The sample was one
of convenience according to the avail-
ability of participants. Power analysis
using SamplePower© 1.0 software in-
dicated that with a sample size of 40 and
alpha set at .05, the study would have a
power of 0.92.
Instruments
The Mishel Uncertainty in Illness
Scale–Community Form (MUIS-C) is
used to measure the uncertainty per-
ceived in illness by those persons who
are not hospitalized (Mishel, 1997). The
MUIS-C is a 23-item scale with a 5-
point Likert-format response set rang-
ing from strongly disagree to strongly
agree. The verb tense has been modified
in three items in consultation with the
author (M. Mishel, personal communi-
cation, September 17, 1997). A score is
obtained for the total scale, which repre-
sents the one-factor. To calculate the
one-factor/total score, all items are
summed. The total uncertainty score
ranges from 23 to 115. Higher scores in-
dicate more uncertainty. The MUIS-C
has been used in samples of participants
with breast cancer and other illnesses
(Mishel, 1997). The reliabilities for the
MUIS-C were reported to be in the
moderate-to-high range (alpha = .74 to
.92). Evidence of content and construct
validity has also been provided (Mishel,
1997).
The Inventory of Functional Status–
Cancer (IFS-CA) measures functional
status in women who have cancer.
Functional status is defined “as a multi-
dimensional concept that encompasses
continuation of usual household and
family, social and community, personal
care, and occupational activities follow-
ing diagnosis of cancer” (Tulman,
Fawcett, & McEvoy, 1991, p. 254). The
IFS-CA is conceptually based on the
Roy adaptation model role function re-
sponse mode, which reflects activities
associated with a person’s primary, sec-
ondary, and tertiary roles (Fawcett &
Tulman, 1996). The IFS-CA, a 39-item
questionnaire, measures the extent to
which the woman continues her usual
activities. All items use a 4-point rating
scale ranging from 1 (not at all) to 4
(fully) for household, family, social, and
community activities; and 1 (never) to 4
(all of the time) for personal care and oc-
cupational activities. The total IFS-CA
score is computed such that the possible
range of scores is 1 to 4; the higher the
score, the greater the total functional
status. The IFS-CA has been used in
women diagnosed with different types
of cancer (Tulman & Fawcett, 1996;
Tulman et al., 1991). Content validity
was established at 98.5%. Test-retest re-
liability coefficient for the total IFS-CA
has been reported at 0.91 (Tulman et al.,
1991).
The Medical Outcomes Study–So-
cial Support Survey (MOS-SSS) is used
to assess the perceived availability, if
needed, of various components of func-
tional support in an adult patient popu-
lation (Sherbourne & Stewart, 1991).
The MOS-SSS is a 19-item survey that
assesses emotional/informational sup-
port, tangible support, affectionate sup-
port, and positive social interaction. All
items use a 5-point Likert response for-
mat with choices ranging from 1 (none
of the time) to 5 (all of the time). The ob-
served scores range from 1 to 5 for the
overall support index. The scores can be
transformed to 0 to 100. Higher scores
indicate more frequent availability of
different types of support, as needed.
The transformed score for the overall
support index was used in the present
study. This tool has been used in various
patient populations, including chroni-
cally ill women. The reported alpha reli-
ability for the total support index is
0.97. Evidence of validity testing with
multitrait scaling has also been reported
(Sherbourne & Stewart, 1991).
The Herth Hope Index (HHI) is used
to assess hope in adult patients within
the clinical setting. Hope is defined as a
multidimensional dynamic life force
characterized by a confident yet uncer-
tain expectation of achieving good,
which to the hoping person is realisti-
cally possible and personally signifi-
cant (Herth, 1992). The HHI is a 12-
item instrument adapted from the Herth
Hope Scale (HHS); it was designed spe-
cifically for clinical application and re-
search. The HHI uses a Likert-type re-
sponse set ranging from 1 (strongly
disagree) to 4 (strongly agree), with a
total range of scores from 12 to 48. The
higher the total scale score, the higher
the level of hope. This tool has been
used in adult men and women diag-
nosed with various types of cancer
(Herth, 1989, 1992). Alpha coefficient
is reported to be 0.97 with a 2-week test-
retest reliability of 0.91; correlation
with the parent HHS is 0.92 (Herth,
1992).
The Profile of Mood States–Short
Form (POMS-SF) is used to identify
and assess transient, fluctuating affec-
tive states. According to McNair, Lorr,
and Droppleman (1992), “The under-
standing of the psychology of emotion
requires not only the inclusion of physi-
ological and behavioral data but also the
subjective data of feeling, affect and
mood” (p. 1). The POMS-SF is a 30-
item measure that uses a 5-point adjec-
tive rating scale ranging from 0 (not at
Cancer Clinical Trials 159
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all) to 4 (extremely) for assessing identi-
fiable mood or affective states: tension-
anxiety, depression-dejection, anger-
hostility, vigor-activity, fatigue-inertia,
and confusion-bewilderment. From the
POMS-SF, a Total Mood Disturbance
(TMD) score is calculated that provides
an overall measure of adjustment. The
score ranges from –20 to 100; the higher
the score, the greater the mood distur-
bance. The POMS has been used in nu-
merous studies of female cancer pa-
tients (McNair et al., 1992). Alpha
reliabilities reported for the POMS-SF
in a female sample range from .75 to .90
(McNair et al., 1992).
Participants also completed a 10-item
demographic data form that ascertained
the following: date, approximate date of
the treatment decision, actual treatment
decision, type and stage of cancer, age,
ethnic group, marital status, educational
level, number of children, employment
status, and financial concern.
Procedures
The appropriate human participants
review committees at each of the four
cancer care facilities approved the
study. Designated clinical trial nurses
(CTNs) at each facility were oriented to
study procedures. The actual data col-
lection procedure was imbedded in the
regular process of clinical trial consid-
eration. The CTN typically saw the pa-
tient after the physician discussed treat-
ment options and provided details of the
treatment trial. When the patient met the
criteria for the present study, the poten-
tial participant was given a brief expla-
nation of the nursing study by the CTN
at the closure of the initial meeting with
the CTN. The patient usually made the
enrollment decision within 2 weeks af-
ter the physician recommendation. At
the point of informing the physician
and/or CTN of the therapy decision, the
patient was again given an explanation
of the nursing study by the CTN. If the
patient was interested in participating,
the informed consent statement at-
tached to the questionnaire was given in
conjunction with verbal instruction for
completion. Completion of the ques-
tionnaire required approximately 15 to
20 minutes. Data from the question-




A convenience sample of 40 women
newly diagnosed with cancer and eligi-
ble for a treatment trial participated. Se-
lect characteristics are presented in Ta-
ble 1. The average age of the
participants was 55.32 years (range = 23
to 76, SD = 12.35). The average number
of years of education completed by the
participants was 13.45 (range = 7 to 17,
SD = 2.12). All participants completed
the questionnaire within 28 days of
making their self-reported treatment de-
cision. The mean time to completion
was 6.02 days (range = 0 to 28, SD =
7.87). Of the participants, 27 (67.5%)
decided to enroll in a treatment trial,
whereas 13 (32.5%) decided not to en-
roll. Efforts were made to obtain a more
evenly distributed sample; however,
each data collection site reported chal-
lenges in securing participants who had
decided not to enroll in a treatment trial.
Hence, the decision was made to use the
present sample because it was sufficient
for the analysis.
Main Study Variables
Preliminary data analysis involved
examination of the main study variables
(uncertainty, role functioning, social
support, hope, and mood state) using
descriptive statistics and comparisons
to the means reported for various sam-
ples in the literature. Table 2 includes
the means, standard deviations, and
ranges of scores for these continuous
variables. The level of statistical signifi-
cance was set at alpha ≤ .05. Tests for
normal distribution were performed on
the data. Distributions from the HHI,
the POMS-SF, and the MOS-SSS were
all negatively skewed. Because the sam-
ple did not meet the criteria for normal
distribution, nonparametric statistics
were used to perform data analysis.
Data analysis to answer the first re-
search question involved examination
of the Spearman rank-order correlation
coefficients among the main study vari-
ables (see Table 3). The initial part of
this question sought to examine the re-
lationship of hope to the three variables
of uncertainty, role functioning, and so-
cial support. All of the three variables
had a statistically significant relation-
ship with the variable of hope. Uncer-
tainty was negatively correlated with
hope (rs = –.557, p = .0001), whereas
role functioning and social support
were positively correlated with hope (rs
= .451, p= .004; rs = .434, p= .005). The
second part of this question sought to
examine the relationship of mood state
to the three variables of uncertainty, role
functioning, and social support. Two of
the three variables had a statistically
significant relationship to the variable
of mood state. Uncertainty was posi-
tively correlated with mood disturbance
(rs = .501, p = .001), whereas role func-
tioning was negatively correlated with
mood disturbance (rs = –.448, p = .004).
There was no statistically significant re-
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lationship between social support and
mood state (rs = –.170, p = .294).
For the second research question, a
point biserial correlation was to be un-
dertaken to examine the strength of the
association between emotional health
(hope and mood state) and the treatment
decision. However, the critical assump-
tions for the statistic could not be met.
Thus, the Mann-Whitney U Test was
used to examine hope and mood state
among women who enrolled in a treat-
ment trial and those who did not. There
was no significant difference in the level
of hope among women who enrolled in
a treatment trial and those who did not
(z = –.102, p = .919). There was also no
significant difference in the level of
mood disturbance among women who
enrolled in the trial and those who did




The first research question examined
the extent of the relationships among
personal, interpersonal, and social sys-
tems concepts and emotional health.
Uncertainty, role functioning, and so-
cial support were all significantly corre-
lated with hope, whereas uncertainty
and role functioning were also signifi-
cantly correlated with mood state. The
magnitude of all of these associations
was either interpreted as moderate or
strong. Surprisingly, there was no statis-
tically significant relationship between
social support and mood state. In terms
of the theory, these findings suggest suf-
ficient empirical evidence for how se-
lect concepts from the personal, inter-
personal, and social systems relate to
emotional health, an aspect of health as
a whole, reflecting an organismic view
of the individual. King (1995) main-
tained that the goal of her nursing sys-
tem, as a whole, is health for individu-
als. Nonetheless, the specific finding
that social support was not significantly
related to mood state was not as the the-
ory predicted. Because social support
was significantly related to hope, it
raises questions about the relationship
between social support and the indica-
tors of emotional health. It may be that
hope is a mediating variable and that
mood state is the outcome variable. It
may also be that the two indicators of
emotional health interact differently
with the systems variable of social sup-
port. Path analytic research is indicated
to answer this question.
In nursing practice, CTNs are fre-
quently involved in alleviating uncer-
tainty in the illness situation, assisting
women with role functioning issues,
and providing professional support.
Clinical trial nurses engaging in these
professional activities may have an ef-
fect on emotional health among women
eligible for a cancer clinical trial. In me-
diating uncertainty, Ruckdeschel,
Albrecht, Blanchard, and Hemmick
(1996) suggested that nurses and physi-
cians need to frame the accrual process
as a prime opportunity for meeting pa-
tient information needs and, impor-
tantly, providing an explanation of com-
plex, ambiguous elements of the disease
and disease experience. Furthermore,
CTNs should be more keenly aware of
the support they provide to women ei-
ther eligible for a cancer clinical trial
during the decision-making process or
already enrolled in a clinical trial. A re-
cent study by Skrutkowska and Weijer
(1997) found that women with breast
cancer enrolled in clinical trials had
more phone interactions with nursing
staff (p = .003) and received teaching (p
< .001) and reassurance (p = .005) from
nursing staff more often than women
not enrolled in clinical trials.
Emotional Health and
the Treatment Decision
The second question sought to exam-
ine the relationship between emotional
health and the treatment decision. There
was no significant difference in the pre-
sentation of emotional health between
the two groups of women. Although this
finding was unexpected, the sample was
not as evenly distributed as desired be-
tween women who chose to enroll and
those who did not.
An additional explanation for the
lack of significant findings may be re-
lated to the instruments themselves and
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Table 2
Means, Standard Deviations, and Ranges of Main Variables
for Sample (N = 40)
Variable M SD Range
Uncertainty (MUIS-C) 47.92 14.06 26 to 100
Role functioning (IFS-CA) 3.09 0.47 1.77 to 3.94
Social support (MOS-SSS) 87.36 18.77 32 to 100
Hope (HHI) 43.07 4.97 31 to 48
Mood state (POMS-SF) 15.55 20.0 –14 to 58
NOTE: MUIS-C = Mishel Uncertainty in Illness Scale–Community; IFS-CA = Inventory of Functional
Status–Cancer; MOS-SSS = Medical Outcomes Study–Social Support Survey; HHI = Herth Hope Index;
POMS-SF = Profile of Mood States–Short Form.
Table 3
Correlation Matrix for Main Variables
Variable MUIS-C IFS-CA MOS-SSS HHI POMS-SF
Uncertainty (MUIS-C) —
Role functioning (IFS-CA) –.476* —
Social support (MOS-SSS) –.303* .007 —
Hope (HHI) –.557* .451* .434* —
Mood state (POMS-SF) .501* –.448* –.170 –.598* —
NOTE: MUIS-C = Mishel Uncertainty in Illness Scale–Community; IFS-CA = Inventory of Functional
Status–Cancer; MOS-SSS = Medical Outcomes Study–Social Support Survey; HHI = Herth Hope Index;
and POMS-SF = Profile of Mood States–Short Form.
*Spearman rank-order correlation is significant at the .01 level (two-tailed).
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their reference to time. The HHI is a
trait-like instrument that asks the partic-
ipant to respond based on how much
they agree with the statement right now.
In contrast, the POMS-SF is transient-
like instrument that asks the participant
to respond based on how they have been
feeling during the past week. From a
theoretical stance, King (1981) identi-
fied the concept of time as a significant
concept that helps nurses understand
persons as personal systems. King
(1981) defined time “as the duration be-
tween the occurrence of one event and
the occurrence of another event. It is a
change from one state to another state”
(p. 44). In the present study, participants
were asked to respond to the HHI based
on “right now” and to the POMS-SF
based on “during the past week.” King
(1981) stated, “Either lengthening or
shortening the order and duration of
time determines how one perceives the
succession of events in the environ-
ment” (p. 43). Perhaps the response to
the questions on these two instruments
by the participant would have been dif-
ferent than reported had they been simi-
larly oriented to time.
Conceivably, the issue of timing is
more significant than one would have
expected. Hinds (P. Hinds, personal
communication, August 17, 1998)
noted in an ongoing study of decision-
making examining the process parents,
patients, and physicians experience
when making end-of-life decisions that
the highest rate of refusal was within the
first 72 hours, when individuals were
highly emotional. Agreement to partici-
pate in a study about their decision-
making was notably higher 4 to 6 weeks
after making the actual end-of-life deci-
sion. These initial findings suggest the
significant influence of time on the de-
cision-making process (P. Hinds, per-
sonal communication, August 17,
1998).
Whereas all participants completed
the questionnaire within 28 days of
making their self-reported treatment de-
cision, it may very well be that differ-
ences would have been seen in the re-
sponses had the duration of time been
significantly less. This would have cap-
tured the woman’s perception of the
treatment decision even closer to the ac-
tual time of decision-making. Surely,
the timing of the administration of the
questionnaire factors into the present
study results, although only through ad-
ditional studies could one confirm this.
Unfortunately, most other studies that
have been done in the area have ex-
tended the time to questionnaire or in-
terview completion (3 to 6 months) by
the participant instead of shortening it,
thus making it difficult to compare find-
ings.
It was proposed in this study that the
treatment decision stems from human
emotion, conceptualized as emotional
health, with the action of decision-mak-
ing manifesting itself in the treatment
decision. Evidently, most of the women
reported hope without significant dif-
ferences in mood disturbance in spite of
the two different decisions (to enter or
not to enter a clinical trial). The exact
reason for this finding remains unclear,
and additional theoretical and design
limitations may exist, necessitating the-
ory revision. Finally, whereas the find-
ings from this research question are
probably related to the decision-making
process as a whole, factors differentiat-
ing those women who did enter a clini-
cal trial and those who did not were not
captured by the present study.
Conclusion
King (1981) clearly stated that the
focus of nursing is the care of human be-
ings with the premise that human beings
are open systems interacting with the
environment. The conceptual frame-
work represents personal, interper-
sonal, and social systems as the domain
of nursing. In the present study, findings
provided empirical evidence of the ade-
quacy of King’s systems framework and
supported, in part, theorized relation-
ships among the critical factors. How-
ever, these factors did not illuminate the
treatment decision.
This study expanded nursing science
as it relates to women eligible for a can-
cer clinical trial by providing a clearer
perspective of the interrelationships
among systems concepts and emotional
health. As Fawcett and Whall (1995)
stated, “The credibility of the general
systems framework requires continuous
investigation by means of systematic
tests of conceptual-theoretical-empiri-
cal structures derived from the frame-
work” (pp. 332-333). Although the
tested theory advances King’s (1981)
systems framework, future research
should focus on theory revision. It is
only with further understanding of the
theoretical concepts underlying enroll-
ment that the appropriate interventions
can be systematically developed, tested,
and incorporated into nursing practice.
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